Abiopharma

Clinical trial NCT07013643 updates: 1. completion date: 2026-12-25 → 2027-07-09 2. primary completion date: 2026-12-25 → 2027-07-09

Clinical trial NCT06380179 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2026-03-02 3. primary completion date: 2025-12-01 → 2026-03-02 4. enrollment: 116 → 29 participants 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: Uniformed Services University of the Health Sciences 7. collaborators removed: Uniformed Services University …

Deadline Approaching: Via Transportation, Inc. (VIA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dana Incorporated (NYSE: DAN)

Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Payoneer Global Inc. (NASDAQ: PAYO)

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Roku, Inc. (NASDAQ: ROKU)

Law Offices of Howard G. Smith Encourages BitGo Holdings, Inc. (BTGO) Shareholders To Inquire About Securities Fraud Class Action

Deadline Soon: LKQ Corporation (LKQ) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Deadline Approaching: Verra Mobility Corporation (VRRM) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith